Skip to main content
CivicGate

HB 54 DE
Became Law

AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE OF EPINEPHRINE AUTOINJECTORS.

DE · session 152 · Assembly / House · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Jan 19, 2023

Latest action (May 25, 2023) Signed by Governor

Summary

Currently, all health insurance plans subject to requirements under Delaware law must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the carrier's drug formulary for individuals who are 18 years of age or younger. This Act expands this requirement to all covered individuals, regardless of age, by January 1, 2024. This Act also makes a technical correction to §§ 3571Y of Title 18 to add standard language about applicability, which is already in § 3370D of Title 18.

Sponsors (19)

Action history (7)

  1. Jan 19, 2023 Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House · lower
  2. Mar 7, 2023 Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 7 Favorable, 5 On Its Merits · lower
  3. Mar 14, 2023 Passed By House. Votes: 39 YES 2 ABSENT · lower
  4. Mar 14, 2023 Assigned to Banking, Business, Insurance & Technology Committee in Senate · upper
  5. Apr 5, 2023 Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 3 Favorable, 3 On Its Merits · upper
  6. May 9, 2023 Passed By Senate. Votes: 20 YES 1 NO · upper
  7. May 25, 2023 Signed by Governor · executive

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →